FIELD: medicine, oncology.
SUBSTANCE: invention can be used for personalized neoadjuvant intra-arterial chemotherapy of gastric cancer. The method includes administration of chemotherapy drugs selectively into the celiac trunk, while 50% of the dose of chemotherapy drugs is injected into the celiac trunk and superselectively 50% of the dose of chemotherapy drugs into the left gastric, gastroduodenal or splenic artery depending on the predominant lesion of the stomach and adjacent organs.
EFFECT: use of the invention allows to increase the operability and effectiveness of treatment, to achieve a significant reduction in the size of the tumor and locoregional metastases due to intra-arterial chemotherapy selectively into the celiac trunk and superselectively into the corresponding artery, taking into account the localization of the tumor in the anatomical region of the stomach in proportion to 50% of the dose for selective and superselective administration drugs.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF NEOADJUVANT CHEMOTHERAPY OF TNM STAGE STOMACH CANCER | 2008 |
|
RU2372902C1 |
METHOD OF TREATING OPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706347C1 |
METHOD OF TREATING OPERABLE GASTRIC ADENOCARCINOMA | 2019 |
|
RU2706346C1 |
METHOD OF TREATING INOPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706341C1 |
METHOD OF TREATING LOCALLY ADVANCED STOMACH CANCER WITH HIGH METABOLIC AND PROLIFERATIVE ACTIVITY | 2014 |
|
RU2552289C1 |
METHOD OF TREATING OPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706339C1 |
METHOD OF COMBINED TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER | 2020 |
|
RU2725079C2 |
METHOD OF STOMACH CARCINOMA TREATMENT | 1996 |
|
RU2134549C1 |
METHOD OF TREATING INOPERABLE PANCREATIC ADENOCARCINOMA WITH LIVER METASTASES | 2019 |
|
RU2706786C1 |
METHOD OF TREATING MALIGNANT GASTRIC AND DUODENAL TUMOURS | 2010 |
|
RU2436605C1 |
Authors
Dates
2023-06-05—Published
2021-06-16—Filed